IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Versant Venture Management, LLC

Q1 2015 Holdings

Filed 2015-04-23 | 6 holdings | $113.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Clovis Oncology, Inc.(CLVSEUR)Common Stock189464100$60.5M814,83353.2%
Five Prime Therapeutics, Inc.(FPRX)Common Stock33830X104$25.0M1,092,15221.9%
Achaogen, Inc.Common Stock004449104$12.5M1,281,15211.0%
CymaBay Therapeutics, Inc.(CBAYUSD)Common Stock23257D103$7.3M1,048,6016.4%
Inogen, Inc.(INGN)Common Stock45780L104$5.0M155,2844.4%
Kythera Biopharmaceuticals, Inc.Common Stock501570105$3.5M70,3763.1%